In this conversation, 4990 discussed various treatments for hair loss, including oral minoxidil, PRP, transplan, Jakinhibitors, Dutasteride, Finasteride, Olumiant, Ketoconazole, RU58841, microneedling, baricitinib, and CCCA. They recommended scalp biopsies in unclear cases of DUPA, twice weekly to twice daily shampooing for topical minoxidil users, and two sessions spaced one month apart with follow up at month three to determine the effectiveness of PRP treatment.
The conversation is about whether it is safe to take Xeljanz, a JAKinhibitor, while also taking finasteride for hair loss. The concern is that Xeljanz weakens the immune system, which could be risky.
The user is experiencing diffuse hair thinning despite using finasteride and oral minoxidil, with no hairline recession or bald spots. Suggestions include checking for telogen effluvium, considering a JAKinhibitor for potential autoimmune issues, and conducting further tests to rule out other causes.
A 35-year-old with alopecia areata has tried finasteride, topical and oral minoxidil, and dutasteride without success in stopping hair loss. The dermatologist suggests JAKinhibitors, but they are too costly, leading to uncertainty about the cause of hair loss.
A 20-year-old user experienced worsening hair loss despite using various treatments including topical and oral minoxidil, finasteride, and dutasteride. Other users suggested additional treatments like JAKinhibitors, RU58841, and lifestyle changes, but the user remains skeptical and frustrated.